1. In this retrospective cost analysis, Medicare spending exceeded $2.9 billion for the 10 most costly brand-name combination medications available from 2011 to 2016. 2. By switching to generic alternatives for these combination drugs, Medicare Part D beneficiaries would have been estimated to save $2.7 billion. Evidence Rating: 2 (Good) Study Rundown: Fixed-dose combination medications […]